TEM · Tempus AI Inc.
AI read · Good for TEM
The AI's read
Growth came from both oncology and Tempus AI’s Data & Applications business. Analysts raised their price targets, though Jefferies moved its rating only to Hold. The strong results and growth across both businesses support the stronger outlook.